Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
When To Implement Zero Based Budgeting In Your Life depends on financial goals and income stability. Start with a basic plan and scale over time.
21,069 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
AI markets are crowded with flashy names, but the real backbone often lies in the companies that enable AI at scale. ...
Ark Invest’s latest stance on quantum computing raises questions for Rigetti Computing. This guide breaks down the im...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
Sprinklr has seen a steep slide, slipping about 40% over the past year. A large fund recently sold close to $3 millio...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
In this guide, we compare how Nvidia and Advanced Micro Devices create revenue, what drives their growth, and why inv...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
This guide breaks down what Greenlight Re (GLRE) investors should watch in the first-quarter 2026 results. Learn how ...
The race to a cleaner power grid is accelerating. Projected annual global renewable energy investment could reach $2....
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...